✦ LIBER ✦

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study

✍ Scribed by Comi, G.; Abramsky, O.; Arbizu, T.; Boyko, A.; Gold, R.; Havrdova, E.; Komoly, S.; Selmaj, K.; Sharrack, B.; Filippi, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of laquinimod on MRI-monitored di

✍ G Comi; A Pulizzi; M Rovaris; O Abramsky; T Arbizu; A Boiko; R Gold; E Havrdova; 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 143 KB

Efficacy and safety of oral fumarate in

✍ Ludwig Kappos; Ralf Gold; David H Miller; David G MacManus; Eva Havrdova; Volker 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 209 KB

Methylprednisolone in combination with i

✍ Mads Ravnborg; Per Soelberg Sørensen; Magnus Andersson; Elisabeth G Celius; Pete 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 374 KB

FP36-WE-02 Clinical outcomes of short-co

✍ G. Giovannoni; G. Comi; S. Cook; K. Rammohan; P. Rieckmann; P. Soelberg-Sørensen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

FP36-WE-03 MRI outcomes of short-course

✍ G. Comi; S. Cook; G. Giovannoni; K. Rammohan; P. Rieckmann; P. Soelberg-Sørensen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Effects of oral glatiramer acetate on cl

✍ Massimo Filippi; Jerry S Wolinsky; Giancarlo Comi 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 185 KB